erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

"it has been a long two years and throughout that time the western trust has not been assisting us in trying to understand the circumstances around our mother's death..

the latest figures mean that since january 2000, scottish widows has paid a total of £2.5bn in claims to more than 86,000 customers..